BSX Q3 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.2B+5.6% YoY

Gross Profit

$1.4B64.9% margin

Operating Income

$376M16.9% margin

Net Income

$283M12.7% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$452M

Free Cash Flow

$350M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$18.6B

Total Liabilities

$11.0B

Stockholders' Equity

$7.6B

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.2B	$2.1B	+5.6%
Gross Profit	$1.4B	$1.4B	+5.9%
Operating Income	$376M	$336M	+11.9%
Net Income	$283M	$228M	+24.1%

Revenue Segments

Cardiovascular

$857M51%

MedSurg

$827M49%